Related Experiment Video

Updated: Aug 26, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity

Thomas R Salas1, Jeri Kim, Funda Vakar-Lopez

  • 1Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|February 27, 2004
PubMed

Insights

Glycogen synthase kinase-3 beta phosphorylates the androgen receptor, inhibiting prostate cancer growth. Inhibiting this kinase reactivates androgen receptor activity, offering a potential therapeutic strategy for prostate cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Kinases play a crucial role in regulating androgen receptor (AR) activity during prostate cancer progression.
  • Androgen receptor signaling is a key driver in the development and advancement of prostate cancer.

Purpose of the Study:

  • To investigate the role of glycogen synthase kinase-3 beta (GSK-3β) in phosphorylating and regulating androgen receptor activity.
  • To explore the therapeutic potential of targeting GSK-3β in prostate cancer.

Main Methods:

  • Western blotting and immunoprecipitation to detect protein interactions and phosphorylation.
  • In vitro kinase assays to assess GSK-3β activity on the androgen receptor.
  • Cell-based assays using inhibitors like lithium chloride and LY294002.
  • Analysis of protein localization in prostate cancer tissue samples.

Main Results:

  • GSK-3β directly phosphorylates the androgen receptor, inhibiting its transcriptional activity.
  • Lithium chloride, a GSK-3β inhibitor, reverses this inhibition, enabling AR-driven transcription.
  • The hinge and ligand-binding domains of the androgen receptor are critical for GSK-3β-mediated regulation.
  • AR phosphorylation is enhanced by LY294002, an indirect inhibitor of Akt, which also inhibits GSK-3β.
  • Mutations in GSK-3β phosphorylation sites affect its nuclear co-localization with AR.
  • Both GSK-3β and AR are found in the nuclei of prostate cancer cells.

Conclusions:

  • GSK-3β-mediated suppression of AR activity is a significant factor in prostate cancer progression.
  • Increased Akt activity, common in advanced prostate cancer, may lead to GSK-3β inhibition, thereby promoting AR signaling.
  • Targeting GSK-3β or modulating its interaction with AR presents a promising therapeutic avenue for prostate cancer treatment.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...